We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Celgene, Novartis File Ritalin Patent Suit

Law360 (November 2, 2007, 12:00 AM EDT) -- Pharmaceutical companies Celgene Corp. and Novartis AG continue to fight back against attempts to market a generic time-release version of Ritalin, a drug used to treat attention deficit/hyperactive disorder.

The companies...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.